If you wish to report an adverse event or product complaint, please call 1-800-LILLYRX(1-800-545-5979)
Baqsimi ® (glucagon) nasal powder
3mgThis information is provided in response to your request. Resources may contain information about doses, uses, formulations and populations different from product labeling. See Prescribing Information above, if applicable.
BAQSIMI™ (glucagon) nasal powder: Use in Elderly
Limited clinical trial experience has not identified differences in responses between the elderly and younger patients when given Baqsimi (glucagon nasal powder).
Clinical studies of Baqsimi did not include sufficient numbers of subjects aged 65 years and over to determine whether they respond differently from younger subjects. Limited clinical trial experience has not identified differences in responses between the elderly and younger patients.1
Enclosed Prescribing Information
BAQSIMI™ (glucagon) nasal powder, for intranasal use, Lilly
1. Baqsimi [package insert]. Indianapolis, IN: Eli Lilly and Company; 2019.
Glossary
Baqsimi = Baqsimi™ (glucagon) nasal powder
Date of Last Review: July 24, 2019
Contact Lilly
Call Us
If you need information about a Lilly product or want to report an Adverse Event or Product Complaint, you may call us.
Available Mon – Friday, 9am-7pm (EST), excluding holidays